RFK Jr. second hearing takeaways: GOP criticism, more Medicare fumbles, and DEI
RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3%, to $457.25, ...
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
RFK Jr. on defensive over vaccine views as key confirmation vote hangs in the balance
Kennedy will also have to win over the swing votes of Sens. Susan Collins, Lisa Murkowski and Mitch McConnell, who have ...
RFK Jr. grilled on Medicare: What is Medicare Part A, Medicare Part B and Medicaid? What are they?
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
5 Health Topics Likely to Come Up During Robert F. Kennedy Jr.’s Hearings
While Mr. Kennedy, seeking the job of health secretary, has been vocal about vaccines and his desire to overhaul the nation’s ...
Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
BioPharma Dive14d
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Medicare’s next drug price negotiations will treat ... rather than treat each use approved by the Food and Drug Administration separately. “The statute and our guidance [are] very clear that when a ...
Federal Register14d
Drug Enforcement Administration
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the "Ryan Haight Act") generally requires an in-person medical evaluation prior to the issuance of a prescription of controlled ...